Citi lowered the firm’s price target on Core Laboratories (CLB) to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLB:
- Core Laboratories N.V. Earnings Call Highlights Challenges and Strategic Gains
- Core Laboratories price target lowered to $13 from $15 at Stifel
- Core Laboratories Reports Q1 2025 Earnings Amid Challenges
- Core Laboratories reports Q1 EPS 14c, consensus 15c
- Core Laboratories sees Q2 EPS 17c-21c, consensus 19c